BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26867970)

  • 1. Knowledge, attitudes and decision-making preferences of men considering participation in the TROG RAVES Prostate Cancer Trial (TROG 08.03).
    Tesson S; Sundaresan P; Ager B; Butow P; Kneebone A; Costa D; Woo H; Pearse M; Juraskova I; Turner S
    Radiother Oncol; 2016 Apr; 119(1):84-90. PubMed ID: 26867970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial evaluating the utility of a patient Decision Aid to improve clinical trial (RAVES 08.03) related decision-making.
    Sundaresan P; Ager B; Turner S; Costa D; Kneebone A; Pearse M; Woo H; Tesson S; Juraskova I; Butow P
    Radiother Oncol; 2017 Oct; 125(1):124-129. PubMed ID: 28844330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03).
    Sundaresan P; Turner S; Kneebone A; Pearse M; Butow P
    Radiother Oncol; 2011 Dec; 101(3):521-4. PubMed ID: 21985948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
    Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A
    BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low conflict and high satisfaction: Decisional outcomes after attending a combined clinic to choose between robotic prostatectomy and radiotherapy for prostate cancer.
    Smith A'; Rincones O; Mancuso P; Sidhom M; Wong K; Berry M; Forstner D; Ngo D; Bokey L; Girgis A
    Urol Oncol; 2022 Jan; 40(1):8.e1-8.e9. PubMed ID: 34116935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Patient Preference Measurement in Decision Aids Improve Decisional Conflict? A Randomized Trial in Men with Prostate Cancer.
    Shirk JD; Crespi CM; Saucedo JD; Lambrechts S; Dahan E; Kaplan R; Saigal C
    Patient; 2017 Dec; 10(6):785-798. PubMed ID: 28623628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Decision Aid to Support Informed Choices for Patients Recently Diagnosed With Prostate Cancer: A Randomized Controlled Trial.
    Chabrera C; Zabalegui A; Bonet M; Caro M; Areal J; González JR; Font A
    Cancer Nurs; 2015; 38(3):E42-50. PubMed ID: 25010250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.
    Gore JL; du Plessis M; Santiago-Jiménez M; Yousefi K; Thompson DJS; Karsh L; Lane BR; Franks M; Chen DYT; Bandyk M; Bianco FJ; Brown G; Clark W; Kibel AS; Kim HL; Lowrance W; Manoharan M; Maroni P; Perrapato S; Sieber P; Trabulsi EJ; Waterhouse R; Davicioni E; Lotan Y; Lin DW
    Cancer; 2017 Aug; 123(15):2850-2859. PubMed ID: 28422278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care.
    Johnson DC; Mueller DE; Deal AM; Dunn MW; Smith AB; Woods ME; Wallen EM; Pruthi RS; Nielsen ME
    J Urol; 2016 Dec; 196(6):1640-1644. PubMed ID: 27346032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the effects of a decision aid for prostate cancer screening.
    Rubel SK; Miller JW; Stephens RL; Xu Y; Scholl LE; Holden EW; Stroud LA; Volk RJ
    J Health Commun; 2010 Apr; 15(3):307-21. PubMed ID: 20432110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: BRECONDA randomized controlled trial results.
    Sherman KA; Kilby CJ; Shaw LK; Winch C; Kirk J; Tucker K; Elder E
    Breast; 2017 Dec; 36():79-85. PubMed ID: 29031121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.
    Gattellari M; Ward JE
    J Med Screen; 2003; 10(1):27-39. PubMed ID: 12790313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Is a "Good" Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer.
    Orom H; Biddle C; Underwood W; Nelson CJ; Homish DL
    Med Decis Making; 2016 Aug; 36(6):714-25. PubMed ID: 26957566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving treatment decision-making in bipolar II disorder: a phase II randomised controlled trial of an online patient decision-aid.
    Fisher A; Keast R; Costa D; Sharpe L; Manicavasagar V; Anderson J; Juraskova I
    BMC Psychiatry; 2020 Sep; 20(1):447. PubMed ID: 32943031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informed decision making among first-degree relatives of prostate cancer survivors: a pilot randomized trial.
    Davis SN; Sutton SK; Vadaparampil ST; Meade CD; Rivers BM; Patel MV; Torres-Roca JF; Heysek RV; Spiess P; Pow-Sang J; Jacobsen PB; Gwede CK
    Contemp Clin Trials; 2014 Nov; 39(2):327-34. PubMed ID: 25465497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do screening trial recruitment logs accurately reflect the eligibility criteria of a given clinical trial? Early lessons from the RAVES 0803 trial.
    Sundaresan P; Turner S; Kneebone A; Pearse M; Fraser-Browne C; Woo HH
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):348-52. PubMed ID: 24685345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy.
    Trada Y; Kneebone A; Paneghel A; Pearse M; Sidhom M; Tang C; Wiltshire K; Haworth A; Fraser-Browne C; Martin J
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1045-51. PubMed ID: 26475066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision-making processes among men with low-risk prostate cancer: A survey study.
    Hoffman RM; Van Den Eeden SK; Davis KM; Lobo T; Luta G; Shan J; Aaronson D; Penson DF; Leimpeter AD; Taylor KL
    Psychooncology; 2018 Jan; 27(1):325-332. PubMed ID: 28612468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer.
    Smith AB; Mancuso P; Sidhom M; Wong K; Berry M; Rincones O; Forstner D; Bokey L; Girgis A
    BMJ Open; 2017 Nov; 7(11):e018403. PubMed ID: 29102996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.